Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / HanAll Biopharma
Company

HanAll Biopharma

Tracked across 1 events · 16 articles · First seen Apr 02, 2026 · Last active May 14, 2026

Sentiment
-30
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 -30
Business
Roivant Brepocitinib Expansion, Immunovant Batoclimab Failure
Impact: HanAll Biopharma is a partner with Immunovant on the development of batoclimab, and the failure of the Phase 3 studies will require them to review future plans.
Apr 02, 2026 · 16 articles
ERGEN INTELLIGENCE
Track HanAll Biopharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.